by Emmanuuel Amadiegwu | Nov 22, 2021 | Pharmacogenomics
Getting Pharmacogenomicsinto the Clinic This Medical News Article Discusses Barriers to Widespread Implementation of Genotype-Guided Prescribing What if there were a way to know if a depressed patient would respond to an antidepressant—before it was prescribed? Or to...
by Emmanuuel Amadiegwu | Nov 21, 2021 | Health and Wellbeing
Polygenic Risk Score Predicts Statin Response Harlan M. Krumholz, MD, SM ReviewingNatarajan P et al. Another stride towards personalised medicine through Statins response. The aspiration of precision medicine is to personalize our approach to individual patients. One...
by Emmanuuel Amadiegwu | Nov 15, 2021 | Hereditary Breast & Ovarian Cancer, Uncategorised
Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry The American Journal of Obstetrics & Gynecology Population-based BRCA1 / BRCA2 testing has been investigated extensively in the Ashkenazi-Jewish (AJ) population and has been...
by Emmanuuel Amadiegwu | Oct 24, 2021 | Uncategorised
Genetic differences mean that a drug can be safe and effective for one person but harmful for another. One person may experience side-effects while another does not, even though they may have been prescribed the same dose. This presents a problem to doctors who have...
by Emmanuuel Amadiegwu | Oct 24, 2021 | Psychiatric Pharmacogenetics Testing
Seventy per cent of children and young people with mental health issues don’t get the right interventions at an early enough age, according to The Children’s Society. Yet, genetic testing could help put an end to this and ensure that individuals receive the right...
Recent Comments